Fabian Gusovsky holds a diploma in pharmacy and biochemistry from the University of Buenos Aires, and a PhD in Pharmacology from Rush University in Chicago, IL. He worked at the NIH, in the Laboratory of Bioorganic Chemistry, NIDDK until 1992. He left to join Eisai Inc, in Andover as a Senior Scientist and was Therapeutic Area Head in Immunology and Atopic diseases by 2007. In 2009, he became a member of the Chief Innovation Officer’s group. As Scientific leader of Eisai’s World Health Initiative he is responsible for a portfolio of projects directed at developing medicines needed for NTDs and Public Health. He is a member of Eisai’s Access to Medicines Group, which is responsible for the DEC donation program through WHO. Among other responsibilities at Eisai, he leads an international project team developing a novel treatment for cerebral malaria.